Clinical Trials Directory

Trials / Completed

CompletedNCT04271371

Preventing Relapse to Smoking Among Prisoners After Release

Preventing Relapse to Smoking Among Prisoners After Release: Developing and Piloting a Complex Health Intervention

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
University of Nottingham · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Accepted

Summary

Prisoners experience huge health inequalities, and their exceptionally high smoking prevalence (five times the national average) contributes significantly to their high mortality. Since the introduction of smoke-free polices across Her Majesty's Prison and Probation Service (HMPPS) in England and Wales, prisoners are now obliged to abstain from smoking while held in prison. This represents a unique opportunity to promote lifelong cessation in this highly disadvantaged and marginalised group. However, evidence suggests most prisoners intend to resume smoking as soon as possible after release. A systematic review of prison smoke-free polices worldwide concluded that there was a need for new research to identify effective strategies to reduce relapse in these individuals.

Detailed description

The primary objective of this study will be to develop and pilot test the feasibility and acceptability of an intervention to help prevent prisoners relapse to smoking after release. The study will work in accordance with the Medical Research Council (MRC) framework for developing and evaluating complex interventions. The Preventing Relapse tO Smoking among PrisonErs after Release (PROSPER) study consists of three key Phases: 1. Document the support provided to manage nicotine addiction during imprisonment and in the periods immediately before and after release; establish the extent to which prisoners intentionally resume or unintentionally relapse to smoking after release; and obtain views on how relapse might be prevented. 2. Drawing on current literature and findings from Phase 1, develop and design an prototype intervention to prevent smoking relapse after release. 3. To pilot the designed prototype intervention and conduct a process evaluation to inform the development of further work in this area. The research will be carried out in three prisons in the East Midlands. The main duties will include recruitment of participants (HMPPS staff members and prisoners), data collection, data analysis, assist with intervention development and refining related intervention materials/resources, co-facilitate Patient and Public Involvement (PPI) groups, contribute to the ethical application for the pilot intervention, and preparation of manuscripts for peer-review publication.

Conditions

Interventions

TypeNameDescription
OTHERNot yet developedA prototype intervention will be developed over Phase 1 \& 2 and piloted in Phase 3 of this study.

Timeline

Start date
2019-08-08
Primary completion
2023-05-01
Completion
2023-12-30
First posted
2020-02-17
Last updated
2024-02-28

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT04271371. Inclusion in this directory is not an endorsement.